Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001078782-16-003720
Filing Date
2016-11-07
Accepted
2016-11-04 19:43:22
Documents
4
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDED ANNUAL REPORT f10ka053116_10kz.htm 10-K/A 213553
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10ka053116_ex31z1.htm EX-31.1 7384
3 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10ka053116_ex32z1.htm EX-32.1 5004
4 IMAGE f10ka053116_10kz001.jpg GRAPHIC 92428
  Complete submission text file 0001078782-16-003720.txt   354048
Mailing Address 9830 6TH STREET, SUITE 103 RANCHO CUCAMONGA CA 91730
Business Address 9830 6TH STREET, SUITE 103 RANCHO CUCAMONGA CA 91730 (855) 476-7679
PROTO SCRIPT PHARMACEUTICAL CORP (Filer) CIK: 0001521420 (see all company filings)

EIN.: 990363803 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-175146 | Film No.: 161976291
SIC: 7330 Services-Mailing, Reproduction, Commercial Art & Photography